Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes

Open access

Abstract

Context: Obesity and insulin resistance in men are linked to decreased testosterone and increased estradiol (E2) levels. Aromatase (ARO) converts testosterone into E2, and this occurs mainly in adipose tissue in men. E2 acts through estrogen receptors ESR1 and ESR2, and they potentially affect development of type 2 diabetes (T2D). Objective: This study explored alterations in ARO, ESR1, and ESR2 in men with obesity or T2D. Methods: Subcutaneous adipose tissue (SAT) from men with or without obesity or T2D was analyzed for ARO, ESR1, and ESR2 gene and protein expression. Data were compared across groups and correlated with markers of obesity, glycemia, insulin resistance, and sex hormones. Moreover, SAT was incubated with E2 or testosterone for ex vivo glucose uptake measurements. Results: ARO levels were higher in SAT from men with obesity compared to nonobese men, and gene expression correlated positively with adiposity, hyperglycemia, and insulin resistance. No association was found between ARO and circulating E2. Men with obesity had lower levels of ESR1 and ESR1:ESR2 ratio, but not ESR2. ESR1 gene expression in SAT correlated negatively with adiposity and insulin resistance markers as well as with ARO expression, and tended to be lower in men with T2D. E2 reduced insulin-stimulated glucose uptake, while testosterone increased basal glucose uptake in adipocytes. Conclusion: Elevated ARO in SAT was found in obese men, and this was linked to insulin resistance and glycemia, supporting the idea that local estrogen production contributes to metabolic dysregulation. ESR1 was reduced in men with T2D and was linked to adiposity and insulin resistance. Taken together, high ARO and altered ESR1:ESR2 balance in SAT in obese men may contribute to insulin resistance and T2D development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaf038

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Gene and protein expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue in men with or without obesity. Gene and protein expression of A and E, ARO; B and F, ESR1; C and G, ESR2; and D, ESR1:ESR2 gene expression ratio in lean men or men with overweight or obesity from cohort 1 (gene expression: n = 10/22/14, lean/overweight/obese; protein expression: n = 7/11, lean/obese; groups matched for age) *P less than .05. Data are mean ± SEM.
Figure 1. Gene and protein expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue in men with or without obesity. Gene and protein expression of A and E, ARO; B and F, ESR1; C and G, ESR2; and D, ESR1:ESR2 gene expression ratio in lean men or men with overweight or obesity from cohort 1 (gene expression: n = 10/22/14, lean/overweight/obese; protein expression: n = 7/11, lean/obese; groups matched for age) *P less than .05. Data are mean ± SEM.CC BY · PubMed Central
Figure 2. Gene and protein expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue in men with or without type 2 diabetes (T2D). Gene and protein expression of A and E, ARO; B and F (F is composite of two separate parts of the blot), ESR1; C and G, ESR2; and D, ESR1:ESR2 gene expression ratio in individuals with no diabetes (ND) or with T2D from cohorts 1 and 2, respectively (gene expression: n = 10/10, protein expression: n = 6/7; ND/T2D; groups matched for age and body mass index). *P less than .05. Data are mean ± SEM.
Figure 2. Gene and protein expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue in men with or without type 2 diabetes (T2D). Gene and protein expression of A and E, ARO; B and F (F is composite of two separate parts of the blot), ESR1; C and G, ESR2; and D, ESR1:ESR2 gene expression ratio in individuals with no diabetes (ND) or with T2D from cohorts 1 and 2, respectively (gene expression: n = 10/10, protein expression: n = 6/7; ND/T2D; groups matched for age and body mass index). *P less than .05. Data are mean ± SEM.CC BY · PubMed Central
Figure 3. Association between the gene expression levels of ARO, ESR1, and ESR2 in subcutaneous adipose tissue (SAT). Association between gene expression of A, ARO and ESR1; B, ESR2; and C, ESR1:ESR2 gene expression. D, Association between gene expression of ESR1 and ESR2 in SAT. Cohorts 1 and 2 including men with and without type 2 diabetes, n = 56. Correlations are Spearman rho.
Figure 3. Association between the gene expression levels of ARO, ESR1, and ESR2 in subcutaneous adipose tissue (SAT). Association between gene expression of A, ARO and ESR1; B, ESR2; and C, ESR1:ESR2 gene expression. D, Association between gene expression of ESR1 and ESR2 in SAT. Cohorts 1 and 2 including men with and without type 2 diabetes, n = 56. Correlations are Spearman rho.CC BY · PubMed Central
Figure 4. Association between the gene expression levels of ARO, ESR1, and ESR2 in subcutaneous adipose tissue with waist-hip ratio (WHR) and homeostatic model assessment of insulin resistance (HOMA-IR). Association between WHR and gene expression of A, ARO; C, ESR1; E, ESR2, and between HOMA-IR and gene expression of B, ARO and D, ESR1; F, ESR2. Cohorts 1 and 2, including men with and without type 2 diabetes, n = 56. Correlations are Spearman rho.
Figure 4. Association between the gene expression levels of ARO, ESR1, and ESR2 in subcutaneous adipose tissue with waist-hip ratio (WHR) and homeostatic model assessment of insulin resistance (HOMA-IR). Association between WHR and gene expression of A, ARO; C, ESR1; E, ESR2, and between HOMA-IR and gene expression of B, ARO and D, ESR1; F, ESR2. Cohorts 1 and 2, including men with and without type 2 diabetes, n = 56. Correlations are Spearman rho.CC BY · PubMed Central
Figure 5. Expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). Gene expression of A, ARO; B, ESR1; C, ESR2; and D, ESR1:ESR2 in paired SAT and VAT surgical samples. Cohort 3, n = 13. E, Immunofluorescence staining of ARO protein and nuclei in SAT histological samples, 20×magnification (representative image, n = 2). Scale bars indicate 100 μm. Lower panel shows zoom of upper panel sections outlined with dashed squares. Presence of ARO indicated with white arrowheads in merged image (lower panel). *P less than .05. Data are mean ± SEM.
Figure 5. Expression of ARO, ESR1, and ESR2 in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). Gene expression of A, ARO; B, ESR1; C, ESR2; and D, ESR1:ESR2 in paired SAT and VAT surgical samples. Cohort 3, n = 13. E, Immunofluorescence staining of ARO protein and nuclei in SAT histological samples, 20×magnification (representative image, n = 2). Scale bars indicate 100 μm. Lower panel shows zoom of upper panel sections outlined with dashed squares. Presence of ARO indicated with white arrowheads in merged image (lower panel). *P less than .05. Data are mean ± SEM.CC BY · PubMed Central
Figure 6. Effect of estradiol (E2) and testosterone on adipocyte glucose uptake. A, Basal and insulin-simulated glucose uptake in adipocytes isolated from subcutaneous adipose tissue from men incubated for 24 hours ex vivo with or without 0.1 nM E2 or 100 nM testosterone and the fold change by B, 25 µU/mL, and C, 1000 µU/mL insulin, respectively, was compared to the basal condition. Data are mean ± SEM, from men with no diabetes (body mass index 23.7-43.8), from cohort 1. E2, n = 10; testosterone, n = 8. The relative increase by insulin was log-transformed prior to statistical analysis. *P less than .05.
Figure 6. Effect of estradiol (E2) and testosterone on adipocyte glucose uptake. A, Basal and insulin-simulated glucose uptake in adipocytes isolated from subcutaneous adipose tissue from men incubated for 24 hours ex vivo with or without 0.1 nM E2 or 100 nM testosterone and the fold change by B, 25 µU/mL, and C, 1000 µU/mL insulin, respectively, was compared to the basal condition. Data are mean ± SEM, from men with no diabetes (body mass index 23.7-43.8), from cohort 1. E2, n = 10; testosterone, n = 8. The relative increase by insulin was log-transformed prior to statistical analysis. *P less than .05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. WHO, 2018, Obesity and Overweight

Cited by

See all 45

Metadata

Authors
Ahmed, F., Hetty, S., Laterveer, R., Surucu, E. B., Mathioudaki, A., Hornbrinck, E., Patsoukaki, V., Olausson, J., Sundbom, M., Svensson, M. K., Pereira, M. J., & Eriksson, J. W.
Affiliations
Uppsala University (SE)
Corresponding author
Eriksson, Jan W
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2025-01-21
Volume
110
Issue
10
Pages
e3410-e3424
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4406604975
Cited by
40
References
47
Citations by year
2026: 24 · 2025: 16
FWCI
23.51
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
Funders
  • Swedish Diabetes Foundation (DIA2021-661)
  • Swedish National Strategic Research Initiative EXODIAB
  • the Family Ernfors Foundation
  • P.O Zetterlings Foundation
  • Swedish Society for Medical Research
  • AstraZeneca R&D
  • NovoNordisk Foundation (NNF20OC0063864, NNF23OC0084483)
  • Agnes and Mac Rudberg Foundation
  • European Commission Horizon RIA (PAS GRAS 101080329)
  • Uppsala University Hospital ALF
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
aromatase, estrogen receptor alpha, estrogen receptor beta, subcutaneous adipose tissue, obesity, type 2 diabetes, insulin resistance, estradiol, testosterone, local estrogen production, glucose uptake, men
MeSH terms
Adipose Tissue, Adult, Aged, Aromatase, Diabetes Mellitus, Type 2, Estradiol, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Testosterone, Estrogen Receptor alpha, Estrogen Receptor beta, Subcutaneous Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/clinem/dgaf038
The paper
Ahmed, F., Hetty, S., Laterveer, R., Surucu, E. B., Mathioudaki, A., Hornbrinck, E., Patsoukaki, V., Olausson, J., Sundbom, M., Svensson, M. K., Pereira, M. J., & Eriksson, J. W. (2025). Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.